1. Home
  2. CRESY vs ESPR Comparison

CRESY vs ESPR Comparison

Compare CRESY & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$10.81

Market Cap

780.9M

Sector

Finance

ML Signal

HOLD

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRESY
ESPR
Founded
1936
2008
Country
Argentina
United States
Employees
2889
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
780.9M
816.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CRESY
ESPR
Price
$10.81
$3.19
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.75
AVG Volume (30 Days)
329.9K
13.6M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
8.14%
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.81
P/E Ratio
$6.92
N/A
Revenue Growth
N/A
21.31
52 Week Low
$8.39
$1.10
52 Week High
$14.21
$4.18

Technical Indicators

Market Signals
Indicator
CRESY
ESPR
Relative Strength Index (RSI) 44.22 65.44
Support Level $10.41 $3.16
Resistance Level $12.29 $3.26
Average True Range (ATR) 0.36 0.02
MACD -0.09 -0.01
Stochastic Oscillator 31.37 83.33

Price Performance

Historical Comparison
CRESY
ESPR

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: